Floatz logo

SALISBURIA MACROPHYLLA LEAF

Depression in Parkinson's Disease

Xuanwu Hospital, BeijingmixturePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Depression in Parkinson's Disease cohort.

Asset / SponsorPhaseRating
Xiaoyao Pill
Xuanwu Hospital, Beijing
Phase 2CCC

Same molecule, other indications

SALISBURIA MACROPHYLLA LEAF is also rated in:

Motoric Cognitive Risk SyndromeDormant
D
Indicative ·
30 / 100
View asset →
cognitive disorderDormant
D
Indicative ·
30 / 100
View asset →
Locomotive SyndromeDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →